Frequent PTEN loss and differential HER2/PI3K signaling pathway alterations in salivary duct carcinoma: Implications for targeted therapy-Reference-Cited by-同舟云学术

Frequent PTEN loss and differential HER2/PI3K signaling pathway alterations in salivary duct carcinoma: Implications for targeted therapy

Published:2018-09-15 Issue:18 Volume:124 Page:3693-3705
ISSN:0008-543X
Container-title:Cancer
language:en
Short-container-title:Cancer

Author:

Saintigny Pierre¹²³,Mitani Yoshitsugu⁴^ORCID,Pytynia Kristen B.⁵,Ferrarotto Renata⁶^ORCID,Roberts Dianna B.⁵,Weber Randal S.⁵,Kies Merrill S.⁶,Maity Sankar N.⁷,Lin Sue-Hwa⁸,El-Naggar Adel K.⁴

Affiliation:

1. Univ Lyon, Université Claude Bernard Lyon 1, INSERM 1052, CNRS 5286, Centre Léon Bérard, Centre de Recherche en Cancérologie de Lyon; Lyon France

2. Department of Translational Research and Innovation; Centre Léon Bérard; Lyon France

3. Department of Medical Oncology; Centre Léon Bérard; Lyon France

4. Department of Pathology; The University of Texas MD Anderson Cancer Center; Houston Texas

5. Department of Head and Neck Surgery; The University of Texas MD Anderson Cancer Center; Houston Texas

6. Department of Thoracic/Head and Neck Medical Oncology; The University of Texas MD Anderson Cancer Center; Houston Texas

7. Department of Genitourinary Medical Oncology; The University of Texas MD Anderson Cancer Center; Houston Texas

8. Department of Translational Molecular Pathology; The University of Texas MD Anderson Cancer Center; Houston Texas

Funder

National Institute of Dental and Craniofacial Research

National Institutes of Health

NIH Office of Rare Diseases Research

Salivary Gland Tumor Cell Biorepository

Head and Neck Specialized Programs of Research Excellence (SPORE)

National Cancer Institute

Publisher

Wiley

Subject

Cancer Research,Oncology

Link

http://onlinelibrary.wiley.com/wol1/doi/10.1002/cncr.31600/fullpdf

Reference64 articles.

1. Salivary duct carcinoma: what is already known, and can we improve survival?;Wee;J Laryngol Otol,2012

2. Salivary duct carcinoma;Murrah;Ann Otol Rhinol Laryngol,1994

3. Salivary duct carcinoma. pt I. A clinicopathologic evaluation and DNA image analysis of 13 cases with review of the literature;Barnes;Oral Surg Oral Med Oral Pathol,1994

4. Mucin-rich variant of salivary duct carcinoma: a clinicopathologic and immunohistochemical study of 4 cases;Simpson;Am J Surg Pathol,2003

5. Primary mucin-producing tumours of the salivary glands: a clinicopathological and morphometric study;Yakirevich;Histopathology,2010

Cited by 27 articles. 订阅此论文施引文献订阅此论文施引文献，注册后可以免费订阅5篇论文的施引文献，订阅后可以查看论文全部施引文献

1. Epithelial‑derived head and neck squamous tumourigenesis (Review);Oncology Reports;2024-08-21

2. Salivary gland carcinoma: Towards a more personalised approach;Cancer Treatment Reviews;2024-03

3. Interpretable Drug Response Prediction through Molecule Structure-aware and Knowledge-Guided Visible Neural Network;2024-02-09

4. Analysis of B7-H4 Expression Across Salivary Gland Carcinomas Reveals Adenoid Cystic Carcinoma–Specific Prognostic Relevance;Modern Pathology;2024-01

5. ERBB2 Amplification and HER2 Expression in Salivary Duct Carcinoma: Evaluation of Scoring Guidelines and Potential for Expanded Anti-HER2 Therapy;Modern Pathology;2023-10